novo nordisk glp-1 products launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk CEO explains why

The receptor binds specifically to GLP-1, a peptide hormone that regulates blood glucose and lipid metabolism

BUSE JB, BODE BW, CHO YM, et al

However, even if findings in one population cannot be generalised to a new setting if the association of interest is modified by patient characteristics, settings, or treatment variations which differ in the new setting, our findings are comparable to those observed in pharmacovigilance and pharmacoepidemiologic studies that do not find increased risk of SIS associated with GLP-1RA

Note: Trulicity is administered once a week, on the same day each week

it felt so easy to apply

[Crossref] [PubMed] Azzam AY, Essibayi MA, Vaishnav D, et al